Bone marrow involvement in follicular lymphoma: Comparison of histology and flow cytometry as staging procedures
暂无分享,去创建一个
H. Höfler | K. Götze | C. Peschel | F. Fend | B. Schmidt | M. Kremer | K. John
[1] J. Briones,et al. Clinical utility of bone marrow flow cytometry in B‐cell non‐Hodgkin lymphomas (B‐NHL) , 2004, Histopathology.
[2] G. Palestro,et al. Flow cytometry in the bone marrow staging of mature B‐cell neoplasms , 2003, Cytometry. Part B, Clinical cytometry.
[3] J. Matthews,et al. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] L. Picker,et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. , 2001, Blood.
[5] H. Höfler,et al. Epstein-Barr Virus–Negative Hodgkin's Lymphoma After Mycosis Fungoides: Molecular Evidence for Distinct Clonal Origin , 2001, Modern Pathology.
[6] J. Luider,et al. Bone marrow staging of patients with non‐Hodgkin lymphoma by flow cytometry , 2000, Cancer.
[7] C. de Wolf‐Peeters,et al. Guidelines for subtyping small B-cell lymphomas in bone marrow biopsies , 1999, Virchows Archiv.
[8] T. Habermann,et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. , 1999, Blood.
[9] J. Armitage,et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] R. Fisher,et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. , 1998, The New England journal of medicine.
[11] C. Dunphy. Combining morphology and flow cytometric immunophenotyping to evaluate bone marrow specimens for B-cell malignant neoplasms. , 1998, American journal of clinical pathology.
[12] M. Naughton,et al. Bone marrow staging in patients with non‐hodgkin's lymphoma , 1998, Cancer.
[13] F. Behm,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations. , 1997, Cytometry.
[14] R. Gascoyne,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. , 1997, Cytometry.
[15] Gregory T Stelzer,et al. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. , 1997, Cytometry.
[16] M. M. Mac Manus,et al. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] K. Maclennan,et al. Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. , 1994, British Journal of Cancer.
[18] P. Isaacson,et al. Bone marrow trephine biopsy in lymphoproliferative disease. , 1992, Journal of clinical pathology.
[19] M. Wolf,et al. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. , 1990, Journal of clinical pathology.
[20] S. Swerdlow,et al. bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. , 2003, American journal of clinical pathology.
[21] C. Palacio,et al. Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas. , 2001, Haematologica.